Table 2: Clinical characteristics of HIV patients who were enrolled for IPT care at Hawassa University Comprehensive specialized Hospital, Sidamma, Ethiopia from January 2015 to December 2020 (n = 483).
Characteristics |
Status at last contact |
Total |
|
Death |
Censored |
||
WHO clinical Stage |
1 |
||
I and II |
6 (1.7%) |
350 (98.3%) |
356 (73.7%) |
III and IV |
20 (15.7%) |
107 (84.3%) |
127 (26.3%) |
CD4 cell count(Cells/µL) |
|||
< = 200 |
12 (17.4%) |
57 (82.6%) |
69 (14.3%) |
> 200 |
14 (3.4%) |
400 (96.6%) |
414 (85.7%) |
Medium of current CD4 count = 456 cells/µL, (IQR, 314-661) and 231 cells/µL (IQR, 105-400) |
|||
BMI |
|||
< 18 kg/m2 |
19 (7.1%) |
248 (92.9%) |
267 (55.3%) |
> 18 kg/m2 |
7 (3.2%) |
209 (96.8%) |
216 (44.7%) |
Medium BMI= 20.29 kg/m2 (IQR, 18.49-22.36) |
|||
CPT use |
|||
Yes |
18 (4.9%) |
350 (95.1%) |
368 (76.2%) |
No |
8 (7.0%) |
107 (93%) |
115 (23.8%) |
IPT use |
|||
Yes |
23 (5.1%) |
430 (94.9%) |
453 (93.8%) |
No |
3 (10.0%) |
27 (90%) |
30 (6.2%) |
HIV/TB co-infection |
|||
Yes |
7 (13.5%) |
45 (86.5%) |
52 (10.8%) |
No |
19 (4.4%) |
4106 (95.6%) |
429 (89.2%) |
Chronic illness |
|||
Yes |
11 (47.8%) |
12 (52.2%) |
23 (4.8%) |
No |
|||
Hemoglobin |
|||
> = 11 mg/dl (Normal) |
16 (4.1%) |
374 (95.9%) |
390 (80.7%) |
< 11 mg/dl (Anemia) |
10 (10.8%) |
83 (89.2%) |
93 (19.3%) |
Functional status |
|||
Working |
3 (0.9%) |
333 (99.1%) |
336 (69.7%) |
Ambulatory |
7 (6.9%) |
99 (93.4%) |
106 (22%) |
Bed ridden |
16 (40%) |
24 (60%) |
40 (8.3%) |